---
title: Î±MT
description: 
published: true
date: 2026-01-30T09:36:59.855Z
tags: 
editor: markdown
dateCreated: 2026-01-30T05:56:52.576Z
---

[â—€è¿”å›](./home.md)

<mark> Î±MT</mark>

# Î±MT

[Summary sheet: Î±MT](/wiki/%CE%91MT/Summary)

| Î±MT | |
| --- | --- |
| [![Î±MT.svg](/æ–‡ä»¶/Î±MT.svg)](/æ–‡ä»¶/Î±MT.svg) | |
| **åŒ–å­¦å‘½å** | |
| å¸¸è§åç§° | *AMT, Î±MT, Indopan* |
| å–ä»£åç§° | *Î±-Methyltryptamine, alpha-methyltryptamine* |
| ç³»ç»Ÿå‘½å | *1-(1H-indol-3-yl)propan-2-amine* |
| **åˆ†ç±»å½’å±** | |
| ç²¾ç¥è¯æ•ˆ | *[å…±æƒ…å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md) / [è¿·å¹»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)* |
| åŒ–å­¦åˆ†ç±» | *[è‰²èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)* |
| **[ç»™è¯é€”å¾„](../æ–‡æ¡£/ç»™è¯é€”å¾„.md)** | |
| - **è­¦å‘Šï¼š** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œä¸ªäººæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»è¾ƒä½å‰‚é‡å¼€å§‹ã€‚ [è¯·å‚é˜…è´Ÿè´£ä»»çš„ç”¨è¯ç« èŠ‚](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚ <br>   <br>    | â‡£ [å£æœ](../æ–‡æ¡£/ç»™è¯é€”å¾„.md#å£æœ) |
| **[ç»™è¯å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md)** | |
| [é˜ˆå€¼](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#é˜ˆå€¼) | 5 mg |
| [è½»å¾®](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#è½»å¾®) | 10 - 25 mg |
| [ä¸­ç­‰](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸­ç­‰) | 25 - 40 mg |
| [å¼ºçƒˆ](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#å¼ºçƒˆ) | 40 - 60 mg |
| [ä¸¥é‡](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸¥é‡) | 60 - 80 mg |
| **[è¯æ•ˆæ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md)** | |
| [æ€»æ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#æ€»æ—¶é•¿) | 13 - 15 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆå‘ä½œ) | 60 - 180 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆè¾¾å³°) | 4 - 6 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆæ®‹ä½™) | 1 - 5 å°æ—¶ |
| <br>   <br>   <br>   <br>   <br>   <br>   <br>   <br>    - **[å…è´£å£°æ˜](../æ–‡æ¡£/å…³äºæœ¬ç«™/å…è´£å£°æ˜.md)ï¼š** æœ¬ç«™çš„[ç»™è¯å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md)ä¿¡æ¯æ”¶é›†è‡ªç”¨æˆ·å’Œ[ç½‘ç»œèµ„æº](../æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)ï¼Œä»…ä¾›æ•™è‚²ç”¨é€”ã€‚è¿™å¹¶éæ¨èï¼Œåº”ä¸å…¶ä»–æ¥æºæ ¸å®ä»¥ç¡®ä¿å‡†ç¡®æ€§ã€‚ | |
| **[è¯ç‰©è”ç”¨](#å±é™©è¯ç‰©è”ç”¨)** | |
| [é…’ç²¾](./é…’ç²¾.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [å’–å•¡å› ](./å’–å•¡å› .md) | âš ï¸ è°¨æ…è”ç”¨ |
| [å¤§éº»](./å¤§éº».md) | âš ï¸ è°¨æ…è”ç”¨ |
|  | |
| [2C-T-x](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2C-T-x.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [5-MeO-xxT](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [è‹¯ä¸™èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‹¯ä¸™èƒºç±»ç‰©è´¨.md) | ğŸ’” è”ç”¨å±é™© |
| [å¯å¡å› ](./å¯å¡å› .md) | ğŸ’” è”ç”¨å±é™© |
| [DOx](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [å³ç¾æ²™èŠ¬](./å³ç¾æ²™èŠ¬.md) | ğŸ’” è”ç”¨å±é™© |
| [å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md) | ğŸ’” è”ç”¨å±é™© |
| [MDMA](./MDMA.md) | ğŸ’” è”ç”¨å±é™© |
| [éº¦æ–¯å¡æ—](./éº¦æ–¯å¡æ—.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [MXE](./MXE.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [25x-NBOMe](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/N-è‹„åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) | âš ï¸ è°¨æ…è”ç”¨ |
| [PCP](./PCP.md) | âš ï¸ è°¨æ…è”ç”¨ |
| SSRIs | ğŸ’” è”ç”¨å±é™© |
| [æ›²é©¬å¤š](./æ›²é©¬å¤š.md) | ğŸ’” è”ç”¨å±é™© |

**Î±-ç”²åŸºè‰²èƒº**ï¼ˆÎ±-Methyltryptamineï¼Œä¹Ÿç§°ä¸º **Indopan**ï¼Œé€šå¸¸ç®€ç§°ä¸º **Î±MT** æˆ– **aMT**ï¼‰æ˜¯[è‰²èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)ç±»åˆ«ä¸­ä¸€ç§è¾ƒä¸ä¸ºäººçŸ¥çš„[å…±æƒ…å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)å‘¢ã€‚[\[1\]](#cite_note-TiHKAL-1)

Î±MT æœ€åˆæ˜¯ç”± Upjohn å…¬å¸åœ¨ 1960 å¹´ä»£å¼€å‘çš„å“¦ã€‚[\[2\]](#cite_note-2) å®ƒæ›¾åœ¨è‹è”ä½œä¸º[æŠ—æŠ‘éƒè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)çŸ­æš‚ä½¿ç”¨ï¼Œå•†å“åä¸º **Indopan**ã€‚[\[1\]](#cite_note-TiHKAL-1)[\[3\]](#cite_note-Barceloux2012-3)[\[4\]](#cite_note-Iversen2013-4)[\[5\]](#cite_note-AcademicPress2013-5) Indopan çš„å¤„æ–¹å‰‚é‡é€šå¸¸åœ¨ 5-10 mg ä¹‹é—´ï¼Œè¿™æ¯”ç”¨äºå¨±ä¹ç”¨é€”çš„å‰‚é‡è¦ä½å¾—å¤šå‘¢ã€‚

Erowid æ”¶åˆ°è¿‡â€œå°‘æ•°æ— æ³•è¯å®çš„æŠ¥å‘Šï¼Œç§°åœ¨æ‘„å…¥é«˜å‰‚é‡ï¼ˆå£æœè¶…è¿‡ 60 mgï¼‰Î±MT åéœ€ä½é™¢æ²»ç–—â€ã€‚[\[6\]](#cite_note-amt-6) ä» 2012 å¹´ Î±MT ä½œä¸ºä¸€ç§åˆæ³•çš„â€œç­–åˆ’è¯â€å¼€å§‹æµè¡Œï¼Œç›´åˆ° 2015 å¹´åˆè¢«ç¦æ­¢ï¼Œè¿™æœŸé—´åœ¨è‹±æ ¼å…°å’Œå¨å°”å£«æœ‰ 22 ä¾‹æ­»äº¡ä¸ Î±MT æœ‰å…³å“¦ã€‚[\[7\]](#cite_note-7)

å…³äº Î±MT çš„è¯ç†ç‰¹æ€§ã€ä»£è°¢å’Œæ¯’æ€§çš„æ•°æ®è¿˜å¾ˆæœ‰é™ï¼Œè€Œä¸”å®ƒçš„éåŒ»ç–—äººç±»ä½¿ç”¨å†å²ä¹Ÿä¸é•¿å‘¢ã€‚
å¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œå¼ºçƒˆå»ºè®®é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)å–µã€‚

## ç›®å½•

* [1 åŒ–å­¦](#åŒ–å­¦)
* [2 è¯ç†å­¦](#è¯ç†å­¦)
* [3 ä¸»è§‚æ•ˆåº”](#ä¸»è§‚æ•ˆåº”)
    * [3.1 **èº¯ä½“æ•ˆåº”**](#èº¯ä½“æ•ˆåº”)
    * [3.2 **è§†è§‰æ•ˆåº”**](#è§†è§‰æ•ˆåº”)
        * [3.2.1 å¢å¼º](#å¢å¼º)
        * [3.2.2 æ‰­æ›²](#æ‰­æ›²)
        * [3.2.3 å‡ ä½•å›¾å½¢](#å‡ ä½•å›¾å½¢)
        * [3.2.4 å¹»è§‰çŠ¶æ€](#å¹»è§‰çŠ¶æ€)
    * [3.3 **è®¤çŸ¥æ•ˆåº”**](#è®¤çŸ¥æ•ˆåº”)
    * [3.4 **å¬è§‰æ•ˆåº”**](#å¬è§‰æ•ˆåº”)
    * [3.5 ä½“éªŒæŠ¥å‘Š](#ä½“éªŒæŠ¥å‘Š)
* [4 æ¯’æ€§å’Œä¼¤å®³æ½œèƒ½](#æ¯’æ€§å’Œä¼¤å®³æ½œèƒ½)
    * [4.1 è€å—æ€§å’Œæˆç˜¾æ½œèƒ½](#è€å—æ€§å’Œæˆç˜¾æ½œèƒ½)
    * [4.2 å±é™©è¯ç‰©è”ç”¨](#å±é™©è¯ç‰©è”ç”¨)
* [5 æ³•å¾‹åœ°ä½](#æ³•å¾‹åœ°ä½)
* [6 å¦è§](#å¦è§)
* [7 å¤–éƒ¨é“¾æ¥](#å¤–éƒ¨é“¾æ¥)
    * [7.1 è®¨è®º](#è®¨è®º)
* [8 å‚è€ƒæ–‡çŒ®](#å‚è€ƒæ–‡çŒ®)

## åŒ–å­¦

Î±MTï¼Œå³ Î±-ç”²åŸºè‰²èƒºï¼Œæ˜¯[è‰²èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)ç±»åˆ«çš„ä¸€ç§åˆæˆå²å“šç”Ÿç‰©ç¢±åˆ†å­ã€‚è‰²èƒºç±»ç‰©è´¨æ‹¥æœ‰ä¸€ä¸ªæ ¸å¿ƒç»“æ„ï¼Œç”±åŒç¯å²å“šæ‚ç¯é€šè¿‡ä¹™åŸºä¾§é“¾è¿æ¥åˆ° R3 ä½çš„æ°¨åŸºç»„æˆã€‚Î±MT åœ¨å…¶è‰²èƒºéª¨æ¶çš„ Î± ç¢³åŸå­ RÎ± å¤„è¢«ä¸€ä¸ªç”²åŸºå–ä»£äº†å‘¢ã€‚

Î±MT ä»¥æ¸¸ç¦»ç¢±å½¢å¼å­˜åœ¨ï¼Œæ˜¯å…¶ (R-) å’Œ (S-) å¯¹æ˜ å¼‚æ„ä½“çš„æ¶ˆæ—‹ä½“ã€‚

## è¯ç†å­¦

å¦è§ï¼š[è¡€æ¸…ç´ èƒ½è‡´å¹»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‡´å¹»å‰‚.md)

Î±MT æ˜¯ä¸€ç§ç›¸å¯¹å¹³è¡¡çš„å†æ‘„å–æŠ‘åˆ¶å‰‚ï¼Œä¹Ÿæ˜¯ä¸‰ç§ä¸»è¦å•èƒºç±»ç¥ç»é€’è´¨ï¼ˆ[è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md)ã€[å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md)å’Œ[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md)ï¼‰çš„é‡Šæ”¾å‰‚ï¼Œ[\[8\]](#cite_note-8) å¹¶ä¸”æ˜¯éé€‰æ‹©æ€§çš„è¡€æ¸…ç´ å—ä½“æ¿€åŠ¨å‰‚å“¦ã€‚[\[9\]](#cite_note-9)

äººä»¬è®¤ä¸º Î±MT çš„[è¿·å¹»](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)æ•ˆæœæ¥è‡ªäºå®ƒåœ¨ [5-HT2A å—ä½“](../æ–‡æ¡£/è¡€æ¸…ç´ .md)ä¸Šä½œä¸º[éƒ¨åˆ†æ¿€åŠ¨å‰‚](../æ–‡æ¡£/å—ä½“æ¿€åŠ¨å‰‚.md)çš„åŠŸæ•ˆå‘¢ã€‚

Î±MT è¿˜ä½œä¸º[è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md)ã€[å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md)å’Œ[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md)çš„[é‡Šæ”¾å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨é‡Šæ”¾å‰‚.md)èµ·ä½œç”¨ã€‚[\[10\]](#cite_note-10)[\[11\]](#cite_note-11) å®ƒåœ¨ä½“å¤–[\[12\]](#cite_note-12)å’Œä½“å†…[\[13\]](#cite_note-13)ä¹Ÿè¡¨ç°å‡ºéå¸¸å¾®å¼±çš„éé€‰æ‹©æ€§ [å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚.md)ï¼ˆRIMAï¼‰æ´»æ€§ï¼Œä½†åœ¨å¸¸è§„å‰‚é‡ä¸‹ï¼Œè¿™ä¸€ç‚¹ä¼¼ä¹ä¸å¤ªé‡è¦ï¼ˆç”šè‡³å¯èƒ½å®Œå…¨ä¸é‡è¦ï¼‰å–µã€‚

## ä¸»è§‚æ•ˆåº”

***å…è´£å£°æ˜ï¼š** ä¸‹åˆ—æ•ˆåº”å¼•ç”¨è‡ª[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](../æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md)ï¼ˆ**SEI**ï¼‰ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ [PsychonautWiki](https://psychonautwiki.org) è´¡çŒ®è€…ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”å¸¦ç€å¥åº·çš„æ€€ç–‘æ€åº¦æ¥çœ‹å¾…è¿™äº›å†…å®¹ã€‚*

*åŒæ ·å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡è¾ƒé«˜çš„å‰‚é‡æ›´å®¹æ˜“è¯±å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚* åŒæ ·ï¼Œ**ä¸è‰¯ååº”**éšç€å‰‚é‡çš„å¢åŠ å¯èƒ½æ€§ä¹Ÿä¼šå¤§å¤§å¢åŠ ï¼Œå¯èƒ½åŒ…æ‹¬**æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”**

*   **[åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)** - å…³äºå…¶å¯¹ä½¿ç”¨è€…èº«ä½“èƒ½é‡æ°´å¹³çš„å½±å“ï¼ŒÎ±MT å¾€å¾€éå¸¸ä»¤äººå…´å¥‹ï¼Œå¯èƒ½å¯¼è‡´ä¸‹é¢šç´§å’¬ä»¥åŠåŒæ‰‹çš„é¢¤æŠ–å’Œä¸ç¨³ã€‚è¿™ç§åˆºæ¿€æ„Ÿä¼šé¼“åŠ±ä½¿ç”¨è€…å››å¤„èµ°åŠ¨ã€å¥”è·‘ã€è·³èˆã€æ”€çˆ¬æˆ–è¿›è¡Œä½“è‚²æ´»åŠ¨ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼Œå…¶ä»–å¸¸è§çš„è¿·å¹»å‰‚å¦‚[èµ›æ´›è¥¿å®¾](../è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)åˆ™æ›´å€¾å‘äºé•‡é™å’Œæ”¾æ¾å‘¢ã€‚
*   **[è‡ªå‘æ€§èº¯ä½“æ„Ÿè§‰](../è¯æ•ˆ/èº¯ä½“æ•ˆåº”.md)** - Î±MT çš„â€œèº¯ä½“é«˜æ½®â€å¯ä»¥æè¿°ä¸ºä¸€ç§å¼ºçƒˆä¸”æŒç»­çš„å…¨èº«æ€§æ„Ÿè§‰ã€‚ä¸å…¶ä»–è¿·å¹»å‰‚ç›¸æ¯”ï¼Œè¿™ç§æ„Ÿè§‰å¹¶ä¸è¡¨ç°ä¸ºè‡ªå‘åœ°åœ¨èº«ä½“ä¸Šä¸‹ç§»åŠ¨çš„ã€ä¸æ–­å˜åŒ–çš„åˆºç—›æ„Ÿï¼›ç›¸åï¼Œå®ƒæ„Ÿè§‰åƒæ˜¯èº«ä½“ä¸Šçš„æ¯ä¸€ä¸ªç¥ç»æœ«æ¢¢éƒ½è¢«æŒç»­åœ°ã€ä¸å˜åœ°æ¿€æ´»ï¼Œè¿™ç§æ„Ÿè§‰è´¯ç©¿æ•´ä¸ªä½“éªŒè¿‡ç¨‹ã€‚è¿™ç§æŒç»­çš„æ„Ÿè§‰éå¸¸ä»¤äººæ„‰æ‚¦ï¼Œä½†åœ¨è¾ƒé«˜å‰‚é‡ä¸‹å¯èƒ½ä¼šå˜å¾—è¿‡äºå¼ºçƒˆï¼Œç”šè‡³æˆä¸ºä¸€ç§è´Ÿæ‹…ã€‚
*   **[æ’å°¿å›°éš¾](../è¯æ•ˆ/æ’å°¿å›°éš¾.md)** - å¶å°”ä¼šå‡ºç°è½»å¾®çš„æ’å°¿å›°éš¾ã€‚
*   **[ä½“æ¸©è°ƒèŠ‚æŠ‘åˆ¶](../è¯æ•ˆ/ä½“æ¸©è°ƒèŠ‚æŠ‘åˆ¶.md)**
*   **[å¤´ç—›](../è¯æ•ˆ/å¤´ç—›.md)** - è®¸å¤šäººæŠ¥å‘Šè¯´åœ¨ä½“éªŒç»“æŸæ—¶ä¼šå‡ºç°å¤´ç—›ã€‚
*   **[å¿ƒå¾‹å¼‚å¸¸](../è¯æ•ˆ/å¿ƒå¾‹å¼‚å¸¸.md)**
*   **[è¡€å‹å‡é«˜](../è¯æ•ˆ/è¡€å‹å‡é«˜.md)**
*   **[å¿ƒç‡å¢å¿«](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)**
*   **[å‡ºæ±—å¢åŠ ](../è¯æ•ˆ/å‡ºæ±—å¢åŠ .md)**
*   **[æ¶å¿ƒ](../è¯æ•ˆ/æ¶å¿ƒ.md)** - ä¸­åº¦åˆ°æåº¦çš„æ¶å¿ƒæ˜¯å¾ˆå¸¸è§çš„æŠ¥å‘Šå‘¢ã€‚ä¸€æ—¦ä½¿ç”¨è€…å‘•åäº†ï¼Œæˆ–è€…éšç€è¯æ•ˆè¾¾å³°ï¼Œè¿™ç§æ„Ÿè§‰é€šå¸¸ä¼šæ¶ˆå¤±æˆ–é€æ¸è‡ªè¡Œæ¶ˆé€€ã€‚
*   **[ç³å­”æ‰©å¤§](../è¯æ•ˆ/ç³å­”æ‰©å¤§.md)**

### **è§†è§‰æ•ˆåº”**

*   Î±MT çš„è§†è§‰æ•ˆæœä¸»è¦åœ¨æ‘„å…¥å¤§å‰‚é‡æ—¶æ‰ä¼šæ˜¾ç°ï¼Œè€Œä¸”ä¸[LSD](./LSD.md)å’Œ[èµ›æ´›è¥¿å®¾](../è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)ç­‰ç‰©è´¨ç›¸æ¯”ï¼Œå…¶è§†è§‰æ•ˆæœç›¸å¯¹äºä¼´éšçš„è®¤çŸ¥å’Œèº¯ä½“æ•ˆåº”çš„å¼ºåº¦æ¥è¯´æ˜¯æ¯”è¾ƒæ¸©å’Œçš„ã€‚

#### å¢å¼º
*   **[è§†è§‰é”åº¦å¢å¼º](../è¯æ•ˆ/è§†è§‰é”åº¦å¢å¼º.md)**
*   **[é¢œè‰²å¢å¼º](../è¯æ•ˆ/é¢œè‰²å¢å¼º.md)**
*   **[æ¨¡å¼è¯†åˆ«å¢å¼º](../è¯æ•ˆ/æ¨¡å¼è¯†åˆ«å¢å¼º.md)**

#### æ‰­æ›²
*   **[æ¼‚ç§»](../è¯æ•ˆ/æ¼‚ç§».md)** *([èåŒ–](../è¯æ•ˆ/æ¼‚ç§».md)ã€[æµåŠ¨](../è¯æ•ˆ/æ¼‚ç§».md)ã€[å‘¼å¸](../è¯æ•ˆ/æ¼‚ç§».md)å’Œ[å˜å½¢](../è¯æ•ˆ/æ¼‚ç§».md))* - ä¸å…¶ä»–[è¿·å¹»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ç›¸æ¯”ï¼Œè¿™ç§æ•ˆæœå¯ä»¥æè¿°ä¸ºé«˜åº¦è¯¦ç»†ã€è¿åŠ¨ç¼“æ…¢è€Œæµç•…ã€å¤–è§‚é™æ­¢ï¼Œé£æ ¼ä¸Šæœ‰äº›ä¸çœŸå®æˆ–å¡é€šåŒ–ã€‚
*   **[å¯¹ç§°æ€§çº¹ç†é‡å¤](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)** - ä¸[LSD](./LSD.md)å’Œ[èµ›æ´›è¥¿å®¾](../è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)ç­‰æ›´å¸¸ç”¨çš„è¿·å¹»å‰‚ç›¸æ¯”ï¼Œè¿™ç§æ•ˆæœåœ¨å¤æ‚æ€§å’Œç²¾ç»†åº¦ä¸Šè¦ä½å¾—å¤šï¼Œå°½ç®¡å®ƒçš„å­˜åœ¨æ„Ÿä¾ç„¶å¾ˆæ˜æ˜¾ã€‚
*   **[æ®‹å½±](../è¯æ•ˆ/æ®‹å½±.md)**
*   **[é¢œè‰²åç§»](../è¯æ•ˆ/é¢œè‰²åç§».md)**
*   **[é£æ™¯åˆ‡ç‰‡](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)**
*   **[ç¤ºè¸ªç°è±¡](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)**

#### [å‡ ä½•å›¾å½¢](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)
*   Î±MT äº§ç”Ÿçš„è§†è§‰å‡ ä½•å›¾å½¢åœ¨å¤–è§‚ä¸Šå¯ä»¥æè¿°ä¸ºæ›´ç±»ä¼¼äº[èµ›æ´›è¥¿å®¾](../è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)å’Œ[2C-E](./2C-E.md)ï¼Œè€Œä¸æ˜¯[LSD](./LSD.md)ã€‚åœ¨è¾ƒä½æ°´å¹³ä¸‹ï¼Œå®ƒå¯èƒ½æ˜¾å¾—å¹³æ·¡å’Œç®€å•ï¼Œä½†åœ¨è¾ƒé«˜å‰‚é‡ä¸‹ï¼Œå…¶å¤æ‚æ€§å’Œæ·±åº¦å¯ä»¥ä¸ä»»ä½•ç»å…¸[è¿·å¹»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)ç›¸åª²ç¾ã€‚å®ƒçš„å‡ ä½•å›¾å½¢å¯ä»¥å…¨é¢åœ°æè¿°ä¸ºï¼šç»“æ„å¤æ‚ï¼ˆåœ¨é‡å‰‚é‡ä¸‹ï¼‰ï¼Œå½¢å¼æŠ½è±¡ï¼Œæ„Ÿè§‰æœ‰æœºï¼Œç»„ç»‡ç»“æ„åŒ–ï¼Œå…‰çº¿æ˜äº®ï¼Œè‰²å½©ä¸°å¯Œï¼Œé˜´å½±æœ‰å…‰æ³½ï¼Œè¾¹ç¼˜æŸ”å’Œä¸é”åˆ©å¹¶å­˜ï¼Œå°ºå¯¸è¾ƒå°ï¼Œé€Ÿåº¦è¾ƒå¿«ï¼Œè¿åŠ¨æµç•…ï¼Œåœ†è§’å’Œæ£±è§’å¹¶å­˜ï¼Œæ·±åº¦éæ²‰æµ¸å¼ï¼Œå¼ºåº¦ä¸€è‡´ã€‚åœ¨è¾ƒé«˜å‰‚é‡ä¸‹ï¼Œè§†è§‰å‡ ä½•å›¾å½¢æ˜æ˜¾æ›´æœ‰å¯èƒ½å¯¼è‡´ [Level 8B](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md) å‡ ä½•çŠ¶æ€ï¼Œè€Œä¸æ˜¯ [Level 8A](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md) å‡ ä½•çŠ¶æ€ã€‚

#### å¹»è§‰çŠ¶æ€
*   **[è½¬åŒ–](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)**
*   **[å†…éƒ¨å¹»è§‰](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)** (*[è‡ªä¸»å®ä½“](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*; *[è®¾å®šã€é£æ™¯å’Œæ™¯è§‚](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*; *[é€è§†å¹»è§‰](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)* å’Œ *[åœºæ™¯ä¸æƒ…èŠ‚](../è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)*) - è¿™ç§ç‰¹å®šçš„æ•ˆæœåœ¨æ—…ç¨‹çš„å‰åŠæ®µå¹¶ä¸å¸¸è§ï¼Œä½†åœ¨ä½“éªŒå¿«ç»“æŸæ—¶å¯èƒ½ä¼šæ˜¾ç°å‡ºæ¥ï¼Œç‰¹åˆ«æ˜¯å¦‚æœç”±äºæŒç»­æ—¶é—´å¼‚å¸¸é•¿è€Œå¯¼è‡´ç¡çœ ä¸è¶³å¼€å§‹äº§ç”Ÿå½±å“çš„è¯ã€‚å†…éƒ¨å¹»è§‰åœ¨é»‘æš—ç¯å¢ƒä¸­æ›´å¸¸è§ï¼Œå¯ä»¥é€šè¿‡å…¶å˜åŒ–å…¨é¢åœ°æè¿°ä¸ºï¼šå¯ä¿¡åº¦æ¸…æ™°ï¼Œé£æ ¼å›ºå®šï¼Œå†…å®¹ä¸ºå…¨æ–°ä½“éªŒï¼Œå¯æ§æ€§è‡ªä¸»ï¼Œé£æ ¼åŸºäºå‡ ä½•å›¾å½¢ï¼Œä¸»é¢˜å‡ ä¹å®Œå…¨æ˜¯ä¸ªäººã€å®—æ•™ã€ç²¾ç¥ã€ç§‘å¹»ã€å¥‡å¹»ã€è¶…ç°å®ã€è’è°¬æˆ–è¶…éªŒæ€§è´¨çš„ã€‚

### **è®¤çŸ¥æ•ˆåº”**

*   ä¸[LSD](./LSD.md)ã€[DMT](./DMT.md)å’Œ[èµ›æ´›è¥¿å®¾](../è¯ç‰©/èµ›æ´›è¥¿å®¾è˜‘è‡.md)ç­‰æ›´ä¼ ç»Ÿçš„è¿·å¹»å‰‚ç›¸æ¯”ï¼ŒÎ±MT çš„æ€ç»´ç©ºé—´è¢«æè¿°ä¸ºæ²¡æœ‰é‚£ä¹ˆæ·±åˆ»ã€å¯Œæœ‰æ´å¯ŸåŠ›æˆ–æ·±è¿œã€‚

    æ— è®ºç¯å¢ƒå¦‚ä½•ï¼Œè¿™äº›è®¤çŸ¥æˆåˆ†çš„æ€»å’Œé€šå¸¸åŒ…æ‹¬ï¼š

*   **[ç„¦è™‘æŠ‘åˆ¶](../è¯æ•ˆ/é•‡é™.md)**
*   **[å»æŠ‘åˆ¶](../è¯æ•ˆ/å»æŠ‘åˆ¶.md)**
*   **[å…±æƒ…ã€æƒ…æ„Ÿå’Œç¤¾äº¤èƒ½åŠ›å¢å¼º](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)** - è¿™ç§æ•ˆæœä¸»è¦ä¸”ä¸€è‡´åœ°è¡¨ç°åœ¨ç¤¾äº¤ç¯å¢ƒä¸­ï¼Œå³å½“ä¸€ä¸ªäººä¸ä»–äººç›¸å¤„æ—¶ã€‚è¿™äº›ç¤¾äº¤ã€çˆ±å’ŒåŒç†å¿ƒçš„æ„Ÿè§‰æ¯”[MDMA](./MDMA.md)ç¨å¼±ï¼Œä¹Ÿæ²¡é‚£ä¹ˆå°–é”ã€‚
*   **[åˆ†æèƒ½åŠ›å¢å¼º](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)** - è¿™ä¸ªæˆåˆ†ä»¥å†…çœä¸ºä¸»ï¼Œä¸”ä¸€è‡´åœ°ä¸»è¦è¡¨ç°åœ¨éç¤¾äº¤ç¯å¢ƒä¸­ï¼Œå³å½“ä½¿ç”¨è€…ç‹¬è‡ªä¸€äººæ—¶ã€‚
*   **[æ¦‚å¿µæ€§æ€ç»´](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æƒ…æ„Ÿå¢å¼º](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[è®¤çŸ¥æ¬£å¿«](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ²‰æµ¸æ„Ÿå¢å¼º](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[éŸ³ä¹æ¬£èµèƒ½åŠ›å¢å¼º](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[è®°å¿†æŠ‘åˆ¶](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
    *   **[è‡ªæˆ‘æ­»äº¡](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ€ç»´åŠ é€Ÿ](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ€ç»´è¿é€šæ€§](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ—¶é—´æ‰­æ›²](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**
*   **[æ¸…é†’åº¦](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md)**

### **å¬è§‰æ•ˆåº”**

*   **[å¢å¼º](../è¯æ•ˆ/å¬è§‰æ•ˆåº”.md)**
*   **[æ‰­æ›²](../è¯æ•ˆ/å¬è§‰æ•ˆåº”.md)**
*   **[å¹»è§‰](../è¯æ•ˆ/å¬è§‰æ•ˆåº”.md)**

### ä½“éªŒæŠ¥å‘Š

åœ¨æˆ‘ä»¬çš„[ä½“éªŒç´¢å¼•](../æ–‡æ¡£/æ•™å­¦ç´¢å¼•é¡µ.md)ä¸­ï¼Œæè¿°è¯¥åŒ–åˆç‰©æ•ˆæœçš„è½¶äº‹æŠ¥å‘ŠåŒ…æ‹¬ï¼š

*   [æŠ¥å‘Š/psychounautwiki/Experience:12 mg AMT - Nicely Surprised](æŠ¥å‘Š/psychounautwiki/Experience:12_mg_AMT_-_Nicely_Surprised)
*   [æŠ¥å‘Š/psychounautwiki/Experience:30mg - Horrible bodyload](æŠ¥å‘Š/psychounautwiki/Experience:30mg_-_Horrible_bodyload)
*   [æŠ¥å‘Š/psychounautwiki/Experience:30mg - Psychostimulant egodeath](æŠ¥å‘Š/psychounautwiki/Experience:30mg_-_Psychostimulant_egodeath)
*   [æŠ¥å‘Š/psychounautwiki/Experience:aMT (70 mg, oral) - Testing AMT to the limit](æŠ¥å‘Š/psychounautwiki/Experience:aMT_(70_mg,_oral)_-_Testing_AMT_to_the_limit)

æ›´å¤šçš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

*   [Erowid Experience Vaults: Î±MT](https://www.erowid.org/experiences/subs/exp_AMT.shtml)

## æ¯’æ€§å’Œä¼¤å®³æ½œèƒ½

- **è¯¥æ¯’æ€§å’Œä¼¤å®³æ½œèƒ½éƒ¨åˆ†æ˜¯ä¸€ä¸ª[å°èŠ‚](../æ–‡æ¡£/å…³äºæœ¬ç«™/å…³äºFreeODwiki.md)ã€‚** å› æ­¤ï¼Œå®ƒå¯èƒ½åŒ…å«ä¸å®Œæ•´ç”šè‡³**å±é™©é”™è¯¯**çš„ä¿¡æ¯ï¼æ‚¨å¯ä»¥é€šè¿‡[ç¼–è¾‘](../æ–‡æ¡£/å…³äºæœ¬ç«™/å…³äºFreeODwiki.md)æ¥å¸®åŠ©æ‰©å±•æˆ–çº æ­£å®ƒã€‚
*æ³¨æ„ï¼šå¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œè¯·åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶å¹¶é‡‡å–**[ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)**ã€‚*

å¦è§ï¼š[ç ”ç©¶ç”¨åŒ–å­¦å“ Â§ æ¯’æ€§å’Œä¼¤å®³æ½œèƒ½](../æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ï¼Œä»¥åŠ[è´Ÿè´£ä»»çš„ç”¨è¯ Â§ è‡´å¹»å‰‚](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)

å…³äºå¨±ä¹æ€§ä½¿ç”¨ Î±MT çš„æ¯’æ€§å’Œé•¿æœŸå¥åº·å½±å“ï¼Œä¼¼ä¹æ²¡æœ‰ä»»ä½•ç§‘å­¦èƒŒæ™¯çš„ç ”ç©¶ï¼Œç¡®åˆ‡çš„ä¸­æ¯’å‰‚é‡ä¹Ÿæ˜¯æœªçŸ¥çš„å–µã€‚è¿™æ˜¯å› ä¸º Î±MT æ˜¯ä¸€ç§äººç±»ä½¿ç”¨å†å²éå¸¸çŸ­çš„[ç ”ç©¶ç”¨åŒ–å­¦å“](../æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ã€‚

ä½œä¸ºä¸€ç§[å•èƒº](../æ–‡æ¡£/ç¥ç»é€’è´¨.md)[å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md)ï¼Œå½“æœç”¨è¿‡é‡æˆ–ä¸[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)ï¼ˆMAOIsï¼‰ã€[å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚.md)ï¼ˆRIMAsï¼‰ã€[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)ä»¥åŠä»»ä½•ä½œä¸º[è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md)å’Œ[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md)çš„[é‡Šæ”¾å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨é‡Šæ”¾å‰‚.md)æˆ–[å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md)çš„ç‰©è´¨è”ç”¨æ—¶ï¼ŒÎ±MT å¯èƒ½æ˜¯å±é™©çš„ã€‚æœ‰ä¸€ä¾‹å…³äº Î±MT çš„æ­»äº¡æŠ¥å‘Šï¼Œä½†ä¸çŸ¥é“æ‘„å…¥äº†å¤šå°‘ã€‚[\[14\]](#cite_note-amt2-14) Erowid å£°æ˜ä»–ä»¬æ”¶åˆ°äº†â€œå°‘æ•°æ— æ³•è¯å®çš„æŠ¥å‘Šï¼Œç§°åœ¨æ‘„å…¥é«˜å‰‚é‡ï¼ˆå£æœè¶…è¿‡ 60 mgï¼‰Î±MT åéœ€ä½é™¢æ²»ç–—â€ã€‚[\[6\]](#cite_note-amt-6)

å€¼å¾—æ³¨æ„çš„æ˜¯ï¼ŒÎ±MT çš„ç±»ä¼¼ç‰© [Î±ET](./Î±ET.md) å·²è¢«è¯æ˜åœ¨éå¸¸é«˜çš„å‰‚é‡ä¸‹ä¼šäº§ç”Ÿé•¿æœŸçš„è¡€æ¸…ç´ ç¥ç»æ¯’æ€§ã€‚[\[15\]](#cite_note-15) Î±MT åœ¨é«˜å‰‚é‡æˆ–é•¿æœŸé‡å¤ä½¿ç”¨ä¸‹ï¼Œå¯èƒ½ä¹Ÿä¼šå¼•èµ·åŒæ ·çš„ç¥ç»æ¯’æ€§å‘¢ã€‚

è½¶äº‹æŠ¥å‘Šè¡¨æ˜ï¼Œä»…ä»…å°è¯•ä½åˆ°ä¸­ç­‰å‰‚é‡çš„ Î±MT ä¸”éå¸¸å¶å°”åœ°ä½¿ç”¨ï¼ˆä½†è¿™ä¸èƒ½å®Œå…¨ä¿è¯å®‰å…¨ï¼‰ï¼Œå¹¶æ²¡æœ‰æ˜æ˜¾çš„è´Ÿé¢å¥åº·å½±å“ã€‚åœ¨æœç”¨ä¹‹å‰ï¼Œåº”å§‹ç»ˆè¿›è¡Œ[ç‹¬ç«‹ç ”ç©¶](https://www.google.com/)ï¼Œä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨è¿™ç§ç‰©è´¨æ—¶é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

### è€å—æ€§å’Œæˆç˜¾æ½œèƒ½

Î±MT è¢«è®¤ä¸ºå…·æœ‰ä¸­ç­‰çš„æˆç˜¾æ€§ã€‚

å¯¹ Î±MT æ•ˆæœçš„è€å—æ€§å‡ ä¹åœ¨æ‘„å…¥åç«‹å³äº§ç”Ÿã€‚ä¹‹åï¼Œå¤§çº¦éœ€è¦ 14 å¤©è€å—æ€§æ‰ä¼šå‡åŠï¼Œ1 ä¸ªæœˆåæ¢å¤åˆ°åŸºçº¿æ°´å¹³ï¼ˆå¦‚æœæ²¡æœ‰è¿›ä¸€æ­¥æ‘„å…¥çš„è¯ï¼‰ã€‚Î±MT ä¸æ‰€æœ‰[è¿·å¹»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è¿·å¹»å‰‚.md)éƒ½å­˜åœ¨äº¤å‰è€å—æ€§ï¼Œè¿™æ„å‘³ç€åœ¨æ‘„å…¥ Î±MT åï¼Œæ‰€æœ‰è¿·å¹»å‰‚çš„æ•ˆæœéƒ½ä¼šé™ä½å“¦ã€‚

### å±é™©è¯ç‰©è”ç”¨

è™½ç„¶å›  Î±MT å¯¼è‡´çš„æ­»äº¡å¾ˆç½•è§[\[6\]](#cite_note-amt-6)[\[14\]](#cite_note-amt2-14)ï¼Œä½†ä½œä¸ºä¸€ç§å¼ºæ•ˆçš„[å•èƒº](../æ–‡æ¡£/ç¥ç»é€’è´¨.md)[å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md)ï¼ˆMRIï¼‰ï¼Œå½“æœç”¨è¿‡é‡æˆ–ä¸è¯¸å¦‚[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)ï¼ˆMAOIsï¼‰ã€[å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å¯é€†æ€§MAOAæŠ‘åˆ¶å‰‚.md)ï¼ˆRIMAsï¼‰ã€[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)ä»¥åŠä»»ä½•ä½œä¸º[ç¥ç»é€’è´¨](../æ–‡æ¡£/ç¥ç»é€’è´¨.md)ï¼ˆå¦‚[è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md)å’Œ[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md)ï¼‰çš„[é‡Šæ”¾å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨é‡Šæ”¾å‰‚.md)æˆ–[å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md)çš„ç‰©è´¨è”ç”¨æ—¶ï¼Œå¯èƒ½ä¼šé€ æˆä¼¤å®³ã€‚[\[16\]](#cite_note-16)

*   **[é…’ç²¾](./é…’ç²¾.md)** - Î±MT åœ¨å¤§è„‘ä¸­æœ‰å¹¿æ³›çš„ä½œç”¨æœºåˆ¶ï¼Œé…’ç²¾ä¹Ÿæ˜¯å¦‚æ­¤ï¼Œæ‰€ä»¥è¿™ç§ç»„åˆçš„æ•ˆæœå¯èƒ½æ— æ³•é¢„æµ‹ã€‚
*   **[å’–å•¡å› ](./å’–å•¡å› .md)** - é«˜å‰‚é‡çš„å’–å•¡å› å¯èƒ½ä¼šå¼•èµ·ç„¦è™‘ï¼Œè¿™åœ¨è¿·å¹»çŠ¶æ€ä¸‹è¾ƒéš¾æ§åˆ¶ï¼Œè€Œä¸”ç”±äºä¸¤è€…éƒ½æœ‰åˆºæ¿€æ€§ï¼Œè¿™ç§ç»„åˆå¯èƒ½ä¼šå¯¼è‡´ä¸€äº›èº«ä½“ä¸é€‚ã€‚
*   **[å¤§éº»](./å¤§éº».md)**
*   **[2C-T-x](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2C-T-x.md)**
*   **[2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md)**
*   **[5-MeO-xxT](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)**
*   **[è‹¯ä¸™èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‹¯ä¸™èƒºç±»ç‰©è´¨.md)**
*   **[å¯å¡å› ](./å¯å¡å› .md)**
*   **[DOx](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md)**
*   **[å³ç¾æ²™èŠ¬](./å³ç¾æ²™èŠ¬.md)**
*   **[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)** - Î±MT æœ¬èº«å°±æ˜¯ä¸€ç§ MAOIã€‚ä½¿ç”¨é…¶æŠ‘åˆ¶å‰‚ä¼šå¤§å¤§é™ä½æ•ˆæœçš„å¯é¢„æµ‹æ€§ã€‚
*   **[MDMA](./MDMA.md)**
*   **[éº¦æ–¯å¡æ—](./éº¦æ–¯å¡æ—.md)**
*   **[MXE](./MXE.md)**
*   **[25x-NBOMe](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/N-è‹„åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md)**
*   **[PCP](./PCP.md)**
*   **SSRIs**
*   **[æ›²é©¬å¤š](./æ›²é©¬å¤š.md)**

## æ³•å¾‹åœ°ä½

æˆªè‡³ 2014 å¹´ï¼ŒÎ±MT å°šæœªå—åˆ°å›½é™…ç®¡åˆ¶å“¦ã€‚[\[17\]](#cite_note-who.int-17)

*   **æ¾³å¤§åˆ©äºš**ï¼šæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT éƒ½æ˜¯è¿æ³•çš„ã€‚å®ƒæ˜¯ä½œä¸º 5-MeO-AMT çš„ç±»ä¼¼ç‰©å—åˆ°ç®¡åˆ¶çš„ï¼Œè€Œåè€…æ˜¯é™„è¡¨ 9 ç®¡åˆ¶ç‰©è´¨ã€‚[\[17\]](#cite_note-who.int-17)
*   **å¥¥åœ°åˆ©**ï¼šæ ¹æ® NPSGï¼ˆæ–°ç²¾ç¥æ´»æ€§ç‰©è´¨æ³•ï¼‰ï¼ŒæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT æ˜¯è¿æ³•çš„ã€‚[\[17\]](#cite_note-who.int-17)
*   **åŠ æ‹¿å¤§**ï¼šåŠ æ‹¿å¤§çš„ã€Šç®¡åˆ¶è¯ç‰©å’Œç‰©è´¨æ³•ã€‹ä¸­æ²¡æœ‰æåŠæ­¤ç‰©è´¨ã€‚[\[18\]](#cite_note-18)
*   **ä¸­å›½**ï¼šæˆªè‡³ 2015 å¹´ 10 æœˆï¼ŒÎ±MT åœ¨ä¸­å›½æ˜¯ç®¡åˆ¶ç‰©è´¨ã€‚[\[19\]](#cite_note-19)
*   **ä¸¹éº¦**ï¼š2010 å¹´ï¼Œä¸¹éº¦å†…æ”¿å’Œå«ç”Ÿéƒ¨é•¿å°† Î±MT åˆ—å…¥ç®¡åˆ¶ç‰©è´¨åå•ï¼ˆæ¸…å• Bï¼‰ã€‚[\[17\]](#cite_note-who.int-17)
*   **å¾·å›½**ï¼šè‡ª 1993 å¹´ 1 æœˆ 31 æ—¥èµ·ï¼ŒÎ±MT æ ¹æ® Anlage I BtMGï¼ˆéº»é†‰å“æ³•ï¼Œé™„è¡¨ Iï¼‰å—åˆ°ç®¡åˆ¶ã€‚[\[20\]](#cite_note-20)[\[21\]](#cite_note-21) æœªç»è®¸å¯åˆ¶é€ ã€æŒæœ‰ã€è¿›å‡ºå£ã€ä¹°å–ã€é‡‡è´­æˆ–åˆ†å‘å‡å±è¿æ³•ã€‚[\[22\]](#cite_note-22)
*   **å¸Œè…Š**ï¼šæ ¹æ®æ³•å¾‹ 4139/2013ï¼ŒæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT æ˜¯è¿æ³•çš„ã€‚[\[23\]](#cite_note-23)
*   **åŒˆç‰™åˆ©**ï¼š2013 å¹´ï¼ŒÎ±MT åœ¨åŒˆç‰™åˆ©è¢«åˆ—å…¥é™„è¡¨ C åå•å—åˆ°ç®¡åˆ¶ã€‚[\[17\]](#cite_note-who.int-17)
*   **æ—¥æœ¬**ï¼šæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT æ˜¯è¿æ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/å…³äºæœ¬ç«™/å…³äºFreeODwiki.md)*\]
*   **æ‹‰è„±ç»´äºš**ï¼šÎ±MT æ˜¯é™„è¡¨ I è¯ç‰©ã€‚[\[24\]](#cite_note-24)
*   **ç«‹é™¶å®›**ï¼šæˆªè‡³ 2012 å¹´ï¼ŒÎ±MT ä½œä¸ºè‰²èƒºè¡ç”Ÿç‰©è¢«åˆ—å…¥éº»é†‰è¯å“å’Œç²¾ç¥è¯ç‰©ç¬¬ 1 æ¸…å•å—åˆ°ç®¡åˆ¶ï¼Œç¦æ­¢ç”¨äºåŒ»ç–—ç›®çš„ã€‚[\[17\]](#cite_note-who.int-17)
*   **ä¿„ç½—æ–¯**ï¼šæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT æ˜¯è¿æ³•çš„ã€‚\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/å…³äºæœ¬ç«™/å…³äºFreeODwiki.md)*\]
*   **æ–¯æ´›ä¼å…‹**ï¼š2013 å¹´ï¼ŒÎ±MT è¢«åˆ—å…¥æ–¯æ´›ä¼å…‹é™„ä»¶ç¬¬ 2 èŠ‚å±é™©ç‰©è´¨æ¸…å•ã€‚[\[17\]](#cite_note-who.int-17)
*   **æ–¯æ´›æ–‡å°¼äºš**ï¼š2013 å¹´ï¼ŒÎ±MT å‡ºç°åœ¨éæ³•è¯ç‰©åˆ†ç±»æ³•ä»¤ä¸­ã€‚[\[17\]](#cite_note-who.int-17)
*   **è¥¿ç­ç‰™**ï¼šæ ¹æ®ã€Šç¦æ­¢æŸäº›å•†å“æ³•ã€‹ï¼ŒÎ±MT å—åˆ°ç®¡åˆ¶ã€‚[\[17\]](#cite_note-who.int-17)
*   **ç‘å…¸**ï¼šæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® Î±MT æ˜¯è¿æ³•çš„ã€‚[\[25\]](#cite_note-25)
*   **ç‘å£«**ï¼šÎ±MT å’Œ AET æ˜¯ Verzeichnis D ä¸‹ç‰¹åˆ«åˆ—åçš„å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[26\]](#cite_note-26)
*   **è‹±å›½**ï¼šç”±äºè‰²èƒºç±»ç‰©è´¨çš„ç»Ÿç§°æ¡æ¬¾ï¼ŒÎ±MT åœ¨è‹±å›½æ˜¯ A ç±»è¯ç‰©ã€‚[\[27\]](#cite_note-27)
*   **ç¾å›½**ï¼šÎ±MT æ˜¯é™„è¡¨ I è¯ç‰©ã€‚2003 å¹´ 4 æœˆ 4 æ—¥ï¼Œç¾å›½ç¼‰æ¯’å±€æ ¹æ®â€œç´§æ€¥åˆ—ç®¡â€ç¨‹åºå°† 5-MeO-DiPT å’Œ Î±MT æ·»åŠ åˆ°ã€Šç®¡åˆ¶ç‰©è´¨æ³•ã€‹çš„é™„è¡¨ I ä¸­ã€‚è¿™äº›è¯ç‰©äº 2004 å¹´ 9 æœˆ 29 æ—¥æ­£å¼è¢«åˆ—å…¥é™„è¡¨ Iã€‚[\[28\]](#cite_note-28)

## å¦è§

*   [è´Ÿè´£ä»»çš„ç”¨è¯](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)
*   [ç ”ç©¶ç”¨åŒ–å­¦å“](../æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)
*   [å…±æƒ…å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)
*   [è‰²èƒºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è‰²èƒºç±»ç‰©è´¨.md)
*   [Î±ET](./Î±ET.md)

## å¤–éƒ¨é“¾æ¥

*   [Î±MT (Wikipedia)](http://en.wikipedia.org/wiki/Alpha-Methyltryptamine)
*   [Î±MT (Erowid Vault)](https://www.erowid.org/chemicals/amt/amt.shtml)
*   [Î±MT (TiHKAL)](https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=48)

### è®¨è®º

*   [The Big and Dandy AMT Thread - 2nd incarnation (Bluelight)](http://www.bluelight.org/vb/threads/344033-The-Big-and-Dandy-AMT-Thread-2nd-incarnation)

## å‚è€ƒæ–‡çŒ®

1.  â†‘ [1.0](#cite_ref-TiHKAL_1-0) [1.1](#cite_ref-TiHKAL_1-1) [Shulgin, Alexander](http://en.wikipedia.org/wiki/Alexander_Shulgin); Shulgin, Ann (1997). ["#48. a-MT"](http://www.erowid.org/library/books_online/tihkal/tihkal48.shtml). *[TiHKAL: The Continuation](http://en.wikipedia.org/wiki/TiHKAL)*. United States: Transform Press. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [0-9630096-9-9](http://en.wikipedia.org/wiki/Special:BookSources/0-9630096-9-9). [OCLC](http://en.wikipedia.org/wiki/OCLC) [38503252](//www.worldcat.org/oclc/38503252).
2.  [â†‘](#cite_ref-2) ["US Patent 3296072 - Method of Treating Mental Depression"](https://patents.google.com/patent/US3296072/en). *Google Patents*. Retrieved July 18, 2020.
3.  [â†‘](#cite_ref-Barceloux2012_3-0) Donald G. Barceloux (March 20, 2012). [*Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants*](https://books.google.com/books?id=OWFiVaDZnkQC&pg=PA196). John Wiley & Sons. pp. 196â€“. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [978-0-471-72760-6](http://en.wikipedia.org/wiki/Special:BookSources/978-0-471-72760-6).
4.  [â†‘](#cite_ref-Iversen2013_4-0) Leslie Iversen (November 11, 2013). [*Handbook of Psychopharmacology: Volume 14 Affective Disorders: Drug Actions in Animals and Man*](https://books.google.com/books?id=ogXrBwAAQBAJ&pg=PA132). Springer Science & Business Media. pp. 132â€“. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [978-1-4613-4045-4](http://en.wikipedia.org/wiki/Special:BookSources/978-1-4613-4045-4).
5.  [â†‘](#cite_ref-AcademicPress2013_5-0) [*Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders*](https://books.google.com/books?id=ZUeCgcrNjOUC&pg=PA632). Academic Press. 17 May 2013. pp. 632â€“. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number) [978-0-12-398360-2](http://en.wikipedia.org/wiki/Special:BookSources/978-0-12-398360-2).
6.  â†‘ [6.0](#cite_ref-amt_6-0) [6.1](#cite_ref-amt_6-1) [6.2](#cite_ref-amt_6-2) ["AMT (Alphamethyltryptamine, IT-290) - Fatalities / Deaths"](https://www.erowid.org/chemicals/amt/amt_death.shtml). Erowid. Retrieved July 18, 2020.
7.  [â†‘](#cite_ref-7) ["Deaths related to drug poisoning, England and Wales"](https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/deathsrelatedtodrugpoisoningenglandandwalesreferencetable). Office for National Statistics. August 15, 2019. Retrieved July 18, 2020.
8.  [â†‘](#cite_ref-8) Nagai, F., Nonaka, R., Satoh Hisashi Kamimura, K. (March 2007). ["The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain"](https://linkinghub.elsevier.com/retrieve/pii/S0014299906013811). *European Journal of Pharmacology*. **559** (2â€“3): 132â€“137. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.ejphar.2006.11.075](//doi.org/10.1016%2Fj.ejphar.2006.11.075). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0014-2999](//www.worldcat.org/issn/0014-2999).
9.  [â†‘](#cite_ref-9) Nonaka, R., Nagai, F., Ogata, A., Satoh, K. (2007). ["In Vitro Screening of Psychoactive Drugs by [35S]GTP.GAMMA.S Binding in Rat Brain Membranes"](http://www.jstage.jst.go.jp/article/bpb/30/12/30_12_2328/_article). *Biological and Pharmaceutical Bulletin*. **30** (12): 2328â€“2333. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1248/bpb.30.2328](//doi.org/10.1248%2Fbpb.30.2328). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0918-6158](//www.worldcat.org/issn/0918-6158).
10. [â†‘](#cite_ref-10) Nagai, F.; Nonaka, R.; Kamimura, K. S. H. (March 22, 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain". *European Journal of Pharmacology*. **559** (2-3): 132â€“137. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.ejphar.2006.11.075](//doi.org/10.1016%2Fj.ejphar.2006.11.075). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1879-0712](//www.worldcat.org/issn/1879-0712). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0014-2999](//www.worldcat.org/issn/0014-2999). [OCLC](http://en.wikipedia.org/wiki/OCLC) [01568459](//www.worldcat.org/oclc/01568459). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [17223101](//www.ncbi.nlm.nih.gov/pubmed/17223101).
11. [â†‘](#cite_ref-11) Nonaka, R.; Nagai, F.; Ogata, A.; Satoh, K. (December 2007). "*In Vitro* Screening of Psychoactive Drugs by [35S]GTPÎ³S Binding in Rat Brain Membranes". *Biological and Pharmaceutical Bulletin*. **30** (12): 2328â€“2333. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1248/bpb.30.2328](//doi.org/10.1248%2Fbpb.30.2328). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1347-5215](//www.worldcat.org/issn/1347-5215). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0918-6158](//www.worldcat.org/issn/0918-6158). [OCLC](http://en.wikipedia.org/wiki/OCLC) [27784830](//www.worldcat.org/oclc/27784830). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [18057721](//www.ncbi.nlm.nih.gov/pubmed/18057721).
12. [â†‘](#cite_ref-12) Arai, Y.; Toyoshima, Y.; Kinemuchi, H. (1986). "Studies of Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase II. Inhibition by Î±-Methylated Substrate-Analogue Monoamines, Î±-Methyltryptamine, Î±-Methylbenzylamine and Two Enantiomers of Î±-Methylbenzylamine". *The Japanese Journal of Pharmacology*. **41** (2): 191â€“197. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1254/jjp.41.191](//doi.org/10.1254%2Fjjp.41.191). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1347-8613](//www.worldcat.org/issn/1347-8613). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [3747266](//www.ncbi.nlm.nih.gov/pubmed/3747266).
13. [â†‘](#cite_ref-13) Greig, M. E.; Walk, R. A.; Gibbons, A. J. (October 1959). ["The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo"](http://jpet.aspetjournals.org/content/127/2/110.short). *Journal of Pharmacology and Experimental Therapeutics*. **127** (2): 110â€“115. [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1521-0103](//www.worldcat.org/issn/1521-0103). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0022-3565](//www.worldcat.org/issn/0022-3565). [OCLC](http://en.wikipedia.org/wiki/OCLC) [1606914](//www.worldcat.org/oclc/1606914). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [13851725](//www.ncbi.nlm.nih.gov/pubmed/13851725).
14. â†‘ [14.0](#cite_ref-amt2_14-0) [14.1](#cite_ref-amt2_14-1) Boland, D. M.; Andollo, W.; Hime, G. W.; Hearn, W. L. (July 1, 2005). "Fatality due to acute alpha-methyltryptamine intoxication". *Journal of Analytical Toxicology*. **29** (5): 394â€“397. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1093/jat/29.5.394](//doi.org/10.1093%2Fjat%2F29.5.394). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1945-2403](//www.worldcat.org/issn/1945-2403). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0146-4760](//www.worldcat.org/issn/0146-4760). [OCLC](http://en.wikipedia.org/wiki/OCLC) [02942106](//www.worldcat.org/oclc/02942106). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [16105268](//www.ncbi.nlm.nih.gov/pubmed/16105268).
15. [â†‘](#cite_ref-15) Huang, X. M.; Johnson, M. P.; [Nichols, D. E.](http://en.wikipedia.org/wiki/David_E._Nichols) (July 23, 1991). "Reduction in brain serotonin markers by Î±-ethyltryptamine (Monase)". *European Journal of Pharmacology*. **200** (1): 187â€“190. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/0014-2999(91)90686-k](//doi.org/10.1016%2F0014-2999%2891%2990686-k). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1879-0712](//www.worldcat.org/issn/1879-0712). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0014-2999](//www.worldcat.org/issn/0014-2999). [OCLC](http://en.wikipedia.org/wiki/OCLC) [01568459](//www.worldcat.org/oclc/01568459). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [1722753](//www.ncbi.nlm.nih.gov/pubmed/1722753).
16. [â†‘](#cite_ref-16) Gillman, P. K. (October 1, 2005). ["Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity"](https://bjanaesthesia.org/article/S0007-0912(17)34956-5/fulltext). *British Journal of Anaesthesia*. **95** (4): 434â€“441. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1093/bja/aei210](//doi.org/10.1093%2Fbja%2Faei210). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [1471-6771](//www.worldcat.org/issn/1471-6771). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0007-0912](//www.worldcat.org/issn/0007-0912). [OCLC](http://en.wikipedia.org/wiki/OCLC) [01537271](//www.worldcat.org/oclc/01537271). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier) [16051647](//www.ncbi.nlm.nih.gov/pubmed/16051647).
17. â†‘ [17.0](#cite_ref-who.int_17-0) [17.1](#cite_ref-who.int_17-1) [17.2](#cite_ref-who.int_17-2) [17.3](#cite_ref-who.int_17-3) [17.4](#cite_ref-who.int_17-4) [17.5](#cite_ref-who.int_17-5) [17.6](#cite_ref-who.int_17-6) [17.7](#cite_ref-who.int_17-7) [17.8](#cite_ref-who.int_17-8) [*Alpha-methyltryptamine (AMT): Critical Review Report*](https://www.who.int/medicines/areas/quality_safety/4_20_Review.pdf) (PDF). Expert Committee on Drug Dependence. Thirty-sixth Meeting. Geneva: World Health Organization (WHO). June 2014. pp. 14â€“15. Agenda item 4.20.
18. [â†‘](#cite_ref-18) ["Controlled Drugs and Substances Act - Schedule I"](http://isomerdesign.com/Cdsa/schedule.php?structure=C). Isomer Design. Retrieved July 18, 2020.
19. [â†‘](#cite_ref-19) ["å…³äºå°å‘ã€Šéè¯ç”¨ç±»éº»é†‰è¯å“å’Œç²¾ç¥è¯å“åˆ—ç®¡åŠæ³•ã€‹çš„é€šçŸ¥"](https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html) (in Chinese). å›½å®¶é£Ÿå“è¯å“ç›‘ç£ç®¡ç†æ€»å±€ [China Food and Drug Administration]. September 27, 2015. Archived from [the original](http://www.sfda.gov.cn/WS01/CL0056/130753.html) on October 1, 2015. Retrieved October 1, 2015.
20. [â†‘](#cite_ref-20) ["BetÃ¤ubungsmittelgesetz (BtMG) Anlage I"](https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html) [Narcotics Act (BtMG) Schedule I] (in German). Bundesamt fÃ¼r Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
21. [â†‘](#cite_ref-21) ["Vierte Verordnung zur Ã„nderung betÃ¤ubungsmittelrechtlicher Vorschriften"](http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl192s2483.pdf) (PDF). *Bundesgesetzblatt Jahrgang 1992 Teil I Nr. 61* (in German). Bundesanzeiger Verlag [Federal Gazette] (published December 31, 1992). December 23, 1992. p. 1058. [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN) [0344-7634](//www.worldcat.org/issn/0344-7634).
22. [â†‘](#cite_ref-22) ["BetÃ¤ubungsmittelgesetz (BtMG) Â§ 29"](https://www.gesetze-im-internet.de/btmg_1981/__29.html) [Narcotics Act (BtMG) Â§ 29] (in German). Bundesamt fÃ¼r Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
23. [â†‘](#cite_ref-23) [*ÎÏŒÎ¼Î¿Ï‚ 4139/2013 - Î¦Î•Îš A-74/20-3-2013 (ÎšÏ‰Î´Î¹ÎºÎ¿Ï€Î¿Î¹Î·Î¼Î­Î½Î¿Ï‚)*](https://www.e-nomothesia.gr/kat-narkotika/n-4139-2013.html)
24. [â†‘](#cite_ref-24) ["Noteikumi par LatvijÄ kontrolÄ“jamajÄm narkotiskajÄm vielÄm, psihotropajÄm vielÄm un prekursoriem"](http://likumi.lv/doc.php?id=121086) (in Latvian). VSIA Latvijas VÄ“stnesis. November 10, 2005. Retrieved January 1, 2020.
25. [â†‘](#cite_ref-25) ["Svensk fÃ¶rfattningssamling FÃ¶rordning om Ã¤ndring i fÃ¶rordningen (1999:58) om fÃ¶rbud mot vissa hÃ¤lsofarliga varor"](http://www.notisum.se/rnp/sls/sfs/20050026.pdf) (PDF) (in Swedish). October 16, 2019. Retrieved July 18, 2020.
26. [â†‘](#cite_ref-26) ["Verordnung des EDI Ã¼ber die Verzeichnisse der BetÃ¤ubungsmittel, psychotropen Stoffe, VorlÃ¤uferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
27. [â†‘](#cite_ref-27) ["Part I: Class A Drugs"](http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I). *"Misuse of Drugs Act 1971"*. UK Government. Retrieved January 7, 2020.
28. [â†‘](#cite_ref-28) ["ALPHA-METHYLTRYPTAMINE"](https://web.archive.org/web/20160128045930/http://webcache.googleusercontent.com/search?q=cache:http://www.deadiversion.usdoj.gov/drug_chem_info/amt.pdf) (PDF). Drug Enforcement Administration. April 2013. Archived from [the original](http://webcache.googleusercontent.com/search?q=cache:http://www.deadiversion.usdoj.gov/drug_chem_info/amt.pdf) (PDF) on January 28, 2016. Retrieved July 18, 2020.